322 related articles for article (PubMed ID: 29118230)
41. With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control study.
Liu LT; Chen QY; Tang LQ; Zhang L; Guo SS; Guo L; Mo HY; Zhao C; Guo X; Chen MY; Qian CN; Zeng MS; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
BMC Cancer; 2016 Oct; 16(1):774. PubMed ID: 27717335
[TBL] [Abstract][Full Text] [Related]
42. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
[TBL] [Abstract][Full Text] [Related]
43. Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.
Su Z; Mao YP; Tang J; Lan XW; OuYang PY; Xie FY
Tumour Biol; 2016 Apr; 37(4):4429-38. PubMed ID: 26499947
[TBL] [Abstract][Full Text] [Related]
44. Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta, Indonesia: A hospital-based retrospective study.
Hutajulu SH; Howdon D; Taroeno-Hariadi KW; Hardianti MS; Purwanto I; Indrasari SR; Herdini C; Hariwiyanto B; Ghozali A; Kusumo H; Dhamiyati W; Dwidanarti SR; Tan IB; Kurnianda J; Allsop MJ
PLoS One; 2021; 16(2):e0246638. PubMed ID: 33577563
[TBL] [Abstract][Full Text] [Related]
45. Retrospective analysis of 234 nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis: therapeutic approaches and prognostic factors.
Zeng L; Tian YM; Huang Y; Sun XM; Wang FH; Deng XW; Han F; Lu TX
PLoS One; 2014; 9(9):e108070. PubMed ID: 25247415
[TBL] [Abstract][Full Text] [Related]
46. Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.
Zeng Q; Wang J; Lv X; Li J; Yin LJ; Xiang YQ; Guo X
BMC Cancer; 2016 Aug; 16(1):693. PubMed ID: 27577729
[TBL] [Abstract][Full Text] [Related]
47. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
[TBL] [Abstract][Full Text] [Related]
48. Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base.
Cushman TR; Shaaban SG; Moreno AC; Lin C; Verma V
Am J Clin Oncol; 2019 Feb; 42(2):154-159. PubMed ID: 30499838
[TBL] [Abstract][Full Text] [Related]
49. Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
Lin C; Lin S; Zhu L; Lin S; Pan J; Xu Y
BMC Cancer; 2022 Jan; 22(1):35. PubMed ID: 34983459
[TBL] [Abstract][Full Text] [Related]
50. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.
Corso CD; Rutter CE; Park HS; Lester-Coll NH; Kim AW; Wilson LD; Husain ZA; Lilenbaum RC; Yu JB; Decker RH
J Clin Oncol; 2015 Dec; 33(36):4240-6. PubMed ID: 26481366
[TBL] [Abstract][Full Text] [Related]
51. Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care.
Gabani P; Barnes J; Lin AJ; Rudra S; Oppelt P; Adkins D; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
Cancer Med; 2018 Aug; 7(8):3592-3603. PubMed ID: 30008178
[TBL] [Abstract][Full Text] [Related]
52. Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.
Han JE; Yi SK; Wang S; Erman A; Bearelly S; Sindhu S; Robbins JR; Bauman J; Hsu CC
Head Neck; 2019 Dec; 41(12):4076-4087. PubMed ID: 31520512
[TBL] [Abstract][Full Text] [Related]
53. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
54. Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma.
Guo R; Mao YP; Chen L; Tang LL; Zhou GQ; Liu LZ; Tian L; Zeng MS; Jia WH; Shao JY; Lin AH; Ma J
Oncotarget; 2017 Feb; 8(6):10594-10601. PubMed ID: 27070084
[TBL] [Abstract][Full Text] [Related]
55. Concurrent chemoradiotherapy for bladder cancer: Practice patterns and outcomes in the general population.
Ghate K; Brennan K; Karim S; Siemens DR; Mackillop WJ; Booth CM
Radiother Oncol; 2018 Apr; 127(1):136-142. PubMed ID: 29306498
[TBL] [Abstract][Full Text] [Related]
56. Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone.
Wu JS; Tsai YC; Jian JJ; Chen HH; Horng CF; Cheng SH
Head Neck; 2018 Sep; 40(9):2070-2077. PubMed ID: 29756398
[TBL] [Abstract][Full Text] [Related]
57. Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas.
Petit C; Blanchard P; Pignon JP; Lueza B
Syst Rev; 2019 Apr; 8(1):96. PubMed ID: 30987679
[TBL] [Abstract][Full Text] [Related]
58. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
[TBL] [Abstract][Full Text] [Related]
59. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
60. M1 stage subdivision and treatment outcome of patients with bone-only metastasis of nasopharyngeal carcinoma.
Shen L; Dong J; Li S; Wang Y; Dong A; Shu W; Wu M; Pan C; Xia Y; Wu P
Oncologist; 2015 Mar; 20(3):291-8. PubMed ID: 25660157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
